Quantification of Proinsulin in Human Plasma by Proteolysis-Aided Peptide Immunoaffinity-Liquid Chromatography-Tandem Mass Spectrometry
Year: 2026
Type: article
Source: Clinical Chemistry
Language: English
Subfield: Spectroscopy
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
Awards: G1567340913, G1874622916, G1941619834, G1979237160, Type 1 Diabetes-A Proposal for Prevention & Intervention, CLINICAL AFFILIATE OF THE TYPE 1 DIABETES TRIALNET, G215324815, Chicagoland Diabetes TrialNet Clinical Center, Quantifying proteins in plasma to democratize personalized medicine for patients with type 1 diabetes, G2290638663, G2564331524, G266093542, G2706744175, G2781497685, G3379626746, G3631080139, G398452873, Type 1 Diabetes TrialNet Clinical Centers - Kansas City, G4055536045, Prediction and Prevention of Type 1 Diabetes (TrialNet), Northwest Clinical Center for Type 1 Diabetes - TrialNet, G4289150930, G447712914, Type 1 Diabetes TrialNet: Toronto Clinical Center, G5473625662, TrialNet at Stanford University, G6107671091, G7319114294, Type 1 diabetes TrialNet Center at Yale University, G7617495748, TrialNet: Diabetes Type 1 Prevention, An Atlanta TrialNet Center: Building a Pathway to 70 Clinical Trial Subjects per Year, Texas Children's Hospital and Baylor College of Medicine TrialNet Clinical Center, G881227773, Nutrition Obesity Research Center, Diabetes Research Center, Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
OpenAlex ID: W7203896050
